SLS SELLAS LIFE SCIENCES GROUP INC Investments/Divestments 8-K Filing 2023 - Offering and Warrant Amendments SELLAS Life Sciences closed its underwritten offering, resulting in net proceeds of $18.5 million and entered into amendments to reduce the exercise price of warrants.Get access to all SEC 8-K filings of the SELLAS LIFE SCIENCES GROUP INC